Valpam 5 5mg recalled over alleged medicine tampering

recall regulatory

Valpam 5 5mg tablets supplied in blister packs of 50 are being recalled due to evidence of medicine tampering

Arrow Pharmaceuticals, in consultation with the TGA, has advised that it is recalling all batches of Valpam 5 5mg (diazepam) because it has been identified that blister pack sheets containing other medicines have been substituted into some packs of Valpam 5.

These medicines may include (but may not be limited to) Amlodipine Sandoz.

Patients are advised not to take Valpam 5 5mg tablets supplied in 50 tablet blister packs and to instead return them to a pharmacy for a refund.

They are being encouraged to return the medicine to the same pharmacy where they purchased it.

“Please note that all tablets or capsules supplied in a pack should be identical and any product names on the blister packs should match those on the external packaging. If you notice any discrepancies with your medicine, talk to your pharmacist,” the TGA advises.

Meanwhile one batch of Amlodipine Sandoz tablets (batch number GT3446, expiry date 10/2019) is also being recalled.

“It has been identified that this medicine may have been dispensed with missing blister sheets, which means affected packs would not contain the correct amount of tablets,” the TGA says.

The news follows last month’s recall of Valium 5mg in blister packs of 50, which were recalled due to the possibility other drugs – including BTC paracetamol codeine tablets, BTC rosuvastatin 10mg tablets and Apotex-Pantoprazole 40mg and 20mg tablets – had been substituted into packs.

A Symbion employee was dismissed following the company’s internal investigation into allegations of tampering, and NSW Police advised.

Previous The week in review
Next Pharmacy titan commended

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.